Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens.

Bordoloi, Devivasha; Xiao, Peng; Choi, Hyeree; Ho, Michelle; Perales-Puchalt, Alfredo; Khoshnejad, Makan; Kim, J Joseph; Humeau, Laurent; Srinivasan, Alagarsamy; Weiner, David B; Muthumani, Kar

Bordoloi, Devivasha; Xiao, Peng; Choi, Hyeree; Ho, Michelle; Perales-Puchalt, Alfredo; Khoshnejad, Makan; Kim, J Joseph; Humeau, Laurent; Srinivasan, Alagarsamy; Weiner, David B; Muthumani, Kar.

Affiliation

Bordoloi D; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Xiao P; authors contributed equally.
Choi H; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Ho M; authors contributed equally.
Perales-Puchalt A; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Khoshnejad M; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Kim JJ; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Humeau L; Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, PA, USA.
Srinivasan A; Inovio Pharmaceuticals, Plymouth Meeting, PA, USA.
Weiner DB; Inovio Pharmaceuticals, Plymouth Meeting, PA, USA.
Muthumani K; NanoBio Diagnostics, West Chester, PA, USA.

Genes Cancer ; 12: 51-64, 2021.

Article de En | MEDLINE | ID: mdl-33884106

Mots clés

immune responses; prostate cancer; synthetic DNA vaccines

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Genes Cancer Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google